Biological E partners with Bavarian Nordic to expand access to Chikungunya vaccine

Hyderabad, Feb. 25 -- Biological E. Limited (BE) on Tuesday announced a strategic partnership with Bavarian Nordic, a global vaccine company, to expand access to Bavarian Nordic's Chikungunya Vaccine in low- and middle-income countries (LMIC).

This partnership comprises a technology transfer of the current drug product manufacturing process for the Chikungunya Vaccine, with the option to transfer the drug substance process at a later stage, Hyderabad-based Pharmaceuticals & Biologics Company BE said in a release here.

To that effect, the companies have reached an agreement to expand their capacity to provide future supplies to endemic low- and middle-income countries.

The initial technology transfer would be followed by regulatory appro...